Circulating Exosomal MicroRNA-21 as a Biomarker in Each Tumor Stage of Colorectal Cancer

Publisher： Karger

E-ISSN： 1423-0232|92|6|360-370

ISSN： 0030-2414

Source： Oncology, Vol.92, Iss.6, 2017-04, pp. : 360-370

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The accuracy of circulating microRNA‐21 in the diagnosis of colorectal cancer: a systematic review and meta‐analysis

By  

COLORECTAL DISEASE, Vol. 17, Iss. 5, 2015-05 ,pp. : O100-O107

John Wiley & Sons Inc

Access to resources Recommend Favorite

Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer

By  

CANCER, Vol. 124, Iss. 4, 2018-02 ,pp. : 785-796

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinicopathological and Prognostic Value of MicroRNA-21 and MicroRNA-155 in Colorectal Cancer

By  

Oncology, Vol. 79, Iss. 3-4, 2011-03 ,pp. : 313-320

Karger

Access to resources Recommend Favorite

MicroRNA–mRNA interactions in colorectal cancer and their role in tumor progression

By  

GENES, CHROMOSOMES AND CANCER, Vol. 54, Iss. 3, 2015-03 ,pp. : 129-141

John Wiley & Sons Inc

Access to resources Recommend Favorite

Circulating MicroRNA-146a and MicroRNA-21 Predict Left Ventricular Remodeling after ST-Elevation Myocardial Infarction

By  

Cardiology, Vol. 132, Iss. 4, 2015-0 ,pp. : 233-241

Karger

Access to resources Recommend Favorite